Global Epidemiology of Buruli Ulcer, 2010-2017, and Analysis of 2014 WHO Programmatic Targets

Standard

Global Epidemiology of Buruli Ulcer, 2010-2017, and Analysis of 2014 WHO Programmatic Targets. / Omansen, Till; Erbowor-Becksen, Alfred ; Yotsu, Rie; van der Werf, Tjip; Tiendrebeogo, Alexander; Grout, Lise; Asiedu, Kingsley.

In: EMERG INFECT DIS, Vol. 25, No. 12, 2019, p. 2183-2190.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Omansen, T, Erbowor-Becksen, A, Yotsu, R, van der Werf, T, Tiendrebeogo, A, Grout, L & Asiedu, K 2019, 'Global Epidemiology of Buruli Ulcer, 2010-2017, and Analysis of 2014 WHO Programmatic Targets', EMERG INFECT DIS, vol. 25, no. 12, pp. 2183-2190.

APA

Omansen, T., Erbowor-Becksen, A., Yotsu, R., van der Werf, T., Tiendrebeogo, A., Grout, L., & Asiedu, K. (2019). Global Epidemiology of Buruli Ulcer, 2010-2017, and Analysis of 2014 WHO Programmatic Targets. EMERG INFECT DIS, 25(12), 2183-2190.

Vancouver

Omansen T, Erbowor-Becksen A, Yotsu R, van der Werf T, Tiendrebeogo A, Grout L et al. Global Epidemiology of Buruli Ulcer, 2010-2017, and Analysis of 2014 WHO Programmatic Targets. EMERG INFECT DIS. 2019;25(12):2183-2190.

Bibtex

@article{489ba7ab6ea44f4a9e1baaa4d0f09028,
title = "Global Epidemiology of Buruli Ulcer, 2010-2017, and Analysis of 2014 WHO Programmatic Targets",
abstract = "Buruli ulcer is a neglected tropical disease caused by Myocobacterium ulcerans; it manifests as a skin lesion, nodule, or ulcer that can be extensive and disabling. To assess the global burden and the progress on disease control, we analyzed epidemiologic data reported by countries to the World Health Organization during 2010–2017. During this period, 23,206 cases of Buruli ulcer were reported. Globally, cases declined to 2,217 in 2017, but local epidemics seem to arise, such as in Australia and Liberia. In 2013, the World Health Organization formulated 4 programmatic targets for Buruli ulcer that addressed PCR confirmation, occurrence of category III (extensive) lesions and ulcerative lesions, and movement limitation caused by the disease. In 2014, only the movement limitation goal was met, and in 2019, none are met, on a global average. Our findings support discussion on future Buruli ulcer policy and post-2020 programmatic targets.",
author = "Till Omansen and Alfred Erbowor-Becksen and Rie Yotsu and {van der Werf}, Tjip and Alexander Tiendrebeogo and Lise Grout and Kingsley Asiedu",
year = "2019",
language = "English",
volume = "25",
pages = "2183--2190",
journal = "EMERG INFECT DIS",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "12",

}

RIS

TY - JOUR

T1 - Global Epidemiology of Buruli Ulcer, 2010-2017, and Analysis of 2014 WHO Programmatic Targets

AU - Omansen, Till

AU - Erbowor-Becksen, Alfred

AU - Yotsu, Rie

AU - van der Werf, Tjip

AU - Tiendrebeogo, Alexander

AU - Grout, Lise

AU - Asiedu, Kingsley

PY - 2019

Y1 - 2019

N2 - Buruli ulcer is a neglected tropical disease caused by Myocobacterium ulcerans; it manifests as a skin lesion, nodule, or ulcer that can be extensive and disabling. To assess the global burden and the progress on disease control, we analyzed epidemiologic data reported by countries to the World Health Organization during 2010–2017. During this period, 23,206 cases of Buruli ulcer were reported. Globally, cases declined to 2,217 in 2017, but local epidemics seem to arise, such as in Australia and Liberia. In 2013, the World Health Organization formulated 4 programmatic targets for Buruli ulcer that addressed PCR confirmation, occurrence of category III (extensive) lesions and ulcerative lesions, and movement limitation caused by the disease. In 2014, only the movement limitation goal was met, and in 2019, none are met, on a global average. Our findings support discussion on future Buruli ulcer policy and post-2020 programmatic targets.

AB - Buruli ulcer is a neglected tropical disease caused by Myocobacterium ulcerans; it manifests as a skin lesion, nodule, or ulcer that can be extensive and disabling. To assess the global burden and the progress on disease control, we analyzed epidemiologic data reported by countries to the World Health Organization during 2010–2017. During this period, 23,206 cases of Buruli ulcer were reported. Globally, cases declined to 2,217 in 2017, but local epidemics seem to arise, such as in Australia and Liberia. In 2013, the World Health Organization formulated 4 programmatic targets for Buruli ulcer that addressed PCR confirmation, occurrence of category III (extensive) lesions and ulcerative lesions, and movement limitation caused by the disease. In 2014, only the movement limitation goal was met, and in 2019, none are met, on a global average. Our findings support discussion on future Buruli ulcer policy and post-2020 programmatic targets.

M3 - SCORING: Journal article

C2 - 31742506

VL - 25

SP - 2183

EP - 2190

JO - EMERG INFECT DIS

JF - EMERG INFECT DIS

SN - 1080-6040

IS - 12

ER -